Trial updateRetina
AMD Ryan Initiative Study (ARIS)
Completed. Registered enrolment: 26. National Eye Institute (NEI)
Trials
Follow recruitment, milestones and posted results.
99 results
Trial updateRetina
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Recruiting. Phase 3. Registered enrolment: 960. Merck Sharp & Dohme LLC
Trial updateRetina
Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents
Recruiting. Phase 4. Registered enrolment: 100. Jaeb Center for Health Research
Trial updateOphthalmology
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Recruiting. Phase 3. Registered enrolment: 426. Jaeb Center for Health Research
Trial updateRetina
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Recruiting. Phase 3. Registered enrolment: 975. Regeneron Pharmaceuticals
Trial updateRetina
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Recruiting. Phase 2 / Phase 3. Registered enrolment: 960. EyeBiotech Ltd.
Trial updateRetina
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Recruiting. Phase 1 / Phase 2. Registered enrolment: 104. Sanofi
Trial updateRetina
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
Active, not recruiting. Phase 3. Registered enrolment: 1126. Regeneron Pharmaceuticals
Trial updateOphthalmology
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
Completed. Phase 2. Registered enrolment: 109. Invirsa, Inc.
Trial updateOphthalmology
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
Completed. Phase 1 / Phase 2. Registered enrolment: 84. Invirsa, Inc.
Trial updateCataract & IOL
Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)
Completed. Registered enrolment: 47. Edinburgh Biosciences Ltd
Trial updateOphthalmology
Screening for Diabetic RETINopathy Using a Non-mydriatic Retinograph Funduscope in Occupational MEDicine
Not yet recruiting. NA. Registered enrolment: 400. University Hospital, Clermont-Ferrand